Skip to main content
. 2021 Dec 24;14(1):87. doi: 10.3390/cancers14010087

Figure 6.

Figure 6

The four types of protein inhibitors in the treatment of hematological malignancies and their mechanisms of action. BCL-2: B-cell leukemia/lymphoma-2. Bim: BCL-2-like protein 11. BAX: BCL-2-associated X protein. BAK: BCL-2 antagonist/killer 1. MOMP: mitochondrial outer membrane permeabilization. XPO1: exportin-1. TSP: tumor suppressor protein. Ub: ubiquitin. ADP: adenosine diphosphate. Created with BioRender.com.